Literature DB >> 873576

Assay of immune cytolysis of lymphocytes and tumour cells by automatic determination of cell volume distribution.

A E Reif, C M Robinson, J S Incze.   

Abstract

Immune cytolysis (lysis) of cells due to the action of antibody in the presence of complement is usually substantiated by the uptake of vital dye by the cells, or by the escape of radiolabel from the cells. Immune cytolysis has now been assayed by determination of cell volume distribution with a Coulter multi-channel particle size analyser used in conjunction with a Coulter counter. For Ehrlich ascites and sarcoma-180 cells, volume degradation corresponding to vital staining was obtained only if trypsin (final concentration 625 microgram/ml) was added immediately after the usual 1 h incubation period for cells, antibody and complement. For L1210 leukaemia cells, trypsin was added at 0 degrees just 1 min before Coulter evaluation, to avoid potentiation of antibody-mediated cell lysis by trypsin. Immune cytolysis of mouse thymic, splenic and lymph node lymphocytes required addition of pronase (final concentration 625 microgram/ml) at 0 degrees for further disruption of antibody-damaged cells, prior to determination of cell volume distribution in the Coulter equipment. Scanning electron micrographs of L1210 cells undergoing immune cytolysis illustrated the changes in cell volume recorded by the Coulter apparatus. This new method for determination of immune cytolysis provides detailed information about the volume distribution of target cells, which permits detection of subtle changes and gives insight into the process of cytolysis. It is not intended to displace other procedures in routine use, except that complete automation of the present method is possible in future.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 873576      PMCID: PMC1445420     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  APPLICATIONS OF ISO-IMMUNE CYTOLYSIS USING RADIOLABELLED TARGET CELLS.

Authors:  A R SANDERSON
Journal:  Nature       Date:  1964-10-17       Impact factor: 49.962

2.  Some further data on cytotoxic isoantibodies in the mouse.

Authors:  E A BOYSE; L J OLD; E STOCKERT
Journal:  Ann N Y Acad Sci       Date:  1962-10-24       Impact factor: 5.691

3.  IMMUNE CYTOLYSIS OF MOUSE THYMIC LYMPHOCYTES.

Authors:  A E REIF
Journal:  J Immunol       Date:  1963-10       Impact factor: 5.422

4.  IN VITRO CYTOTOXIC EFFECT OF ISOANTIBODY MEASURED AS ISOTOPE RELEASE FROM LABELLED TARGET CELL DNA.

Authors:  G KLEIN; P PERLMANN
Journal:  Nature       Date:  1963-08-03       Impact factor: 49.962

5.  QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING CR-51-LABELLED TARGET CELLS.

Authors:  H WIGZELL
Journal:  Transplantation       Date:  1965-05       Impact factor: 4.939

6.  Immune cytolysis of three mouse ascites tumors.

Authors:  A E REIF
Journal:  J Immunol       Date:  1962-12       Impact factor: 5.422

7.  A system for quantitative determination of cytotoxic activity of antisera to ascites tumor cells.

Authors:  A E REIF; H J NORRIS
Journal:  Cancer Res       Date:  1960-09       Impact factor: 12.701

8.  Toxicity of homologous immune serum to a transplantable tumor: studies using phase microscopy and cinemicrography.

Authors:  R SCHREK; F W PRESTON
Journal:  J Natl Cancer Inst       Date:  1956-02       Impact factor: 13.506

9.  Formalin-fixed cell preparations as standards for use in the automated trypan blue cytotoxic assay.

Authors:  W P Drake; P C Ungaro; M R Mardiney
Journal:  Transplantation       Date:  1972-07       Impact factor: 4.939

10.  THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES.

Authors:  A E REIF; J M ALLEN
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

View more
  1 in total

1.  Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration.

Authors:  D L Granger; R R Taintor; J L Cook; J B Hibbs
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.